BURGALETTO, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 410
NA - Nord America 402
AS - Asia 191
SA - Sud America 32
AF - Africa 31
Totale 1.066
Nazione #
US - Stati Uniti d'America 401
IT - Italia 302
SG - Singapore 153
IE - Irlanda 50
BR - Brasile 31
CN - Cina 29
DE - Germania 20
CI - Costa d'Avorio 18
BE - Belgio 10
SN - Senegal 10
RU - Federazione Russa 5
CH - Svizzera 4
FI - Finlandia 4
NL - Olanda 4
GB - Regno Unito 3
IL - Israele 3
FR - Francia 2
NG - Nigeria 2
VN - Vietnam 2
AT - Austria 1
BN - Brunei Darussalam 1
CA - Canada 1
EC - Ecuador 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
IN - India 1
IQ - Iraq 1
PL - Polonia 1
SE - Svezia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 1.066
Città #
Santa Clara 130
Catania 107
Singapore 92
Chandler 57
Chicago 55
Dublin 50
Civitanova Marche 21
Boardman 20
Abidjan 18
Palermo 17
Rome 14
Bremen 12
Cambridge 12
Lawrence 12
Bronte 11
Brussels 10
Dakar 10
Ashburn 9
Hefei 8
Aci Catena 7
Andover 7
Mercogliano 6
Des Moines 5
Amsterdam 4
Lappeenranta 4
Milan 4
Munich 4
Paternò 4
Cagliari 3
Merì 3
Oakland 3
Abano Terme 2
Abuja 2
Baytown 2
Bernareggio 2
Brasília 2
Camerino 2
Crotone 2
Dong Ket 2
Grafing 2
Gravina di Catania 2
Gravina in Puglia 2
Jiaxing 2
Scandicci 2
Sestu 2
Seveso 2
Shanghai 2
Tel Aviv 2
Trieste 2
Zurich 2
Alessandria della Rocca 1
Araxá 1
Bandar Seri Begawan 1
Beijing 1
Belpasso 1
Brescia 1
Brusque 1
Campinas 1
Campos dos Goytacazes 1
Carapicuíba 1
Chongqing 1
Constantina 1
Coria del Río 1
Corrente 1
Cuenca 1
Curitiba 1
Cusano Mutri 1
Edinburgh 1
Fortaleza 1
Frankfurt am Main 1
Guarulhos 1
Hanover 1
Houston 1
Huskvarna 1
Ibirubá 1
Irecê 1
Itapira 1
Jinan 1
Joaçaba 1
Lagoa Santa 1
Librizzi 1
Lusciano 1
Macomer 1
Maletto 1
Manaus 1
Mata de São João 1
Messina 1
Miami 1
Moscow 1
Najaf 1
Nanyang 1
Napoli 1
New York 1
Norwalk 1
Nova Friburgo 1
Nova Lima 1
Nova Odessa 1
Osasco 1
Ouroeste 1
Paterno 1
Totale 807
Nome #
Beneficial effects of curtailing immune susceptibility in an Alzheimer's disease model 103
Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer’s disease 77
Intranasal Administration of a {TRAIL} Neutralizing Monoclonal Antibody Adsorbed in {PLGA} Nanoparticles and {NLC} Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer's Disease 75
Tumor necrosis factor-related apoptosis-inducing ligand reduces the expression of the neuroprotective Na+ /Ca2+ exchanger isoform NCX3 in human neuroblastoma SH-SY5Y cells 71
Beneficial effects of choline alphoscerate on amyloid-β neurotoxicity in an in vitro model of alzheimer’s disease 71
Pharmacological enhancement of cholinergic neurotransmission alleviates neuroinflammation and improves functional outcomes in a triple transgenic mouse model of Alzheimer’s disease 70
The immune system on the TRAIL of Alzheimer’s disease 60
Ocular pharmacological profile of hydrocortisone in dry eye disease 58
TRAIL-R Deficient Mice Are Protected from Neurotoxic Effects of Amyloid-β 53
Role of Microglia and Astrocytes in Alzheimer's Disease: From Neuroinflammation to Ca2+ Homeostasis Dysregulation 51
Repositioning of Immunomodulators: A Ray of Hope for Alzheimer’s Disease? 46
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson’s Disease 46
On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents 44
Alzheimer’s disease modification mediated by bone marrow-derived macrophages via a TREM2-independent pathway in mouse model of amyloidosis 40
In search of an ideal drug for safer treatment of obesity: The false promise of pseudoephedrine 40
Taming Microglia in Alzheimer’s Disease: Exploring Potential Implications of Choline Alphoscerate via α7 nAChR Modulation 38
Lights and shadows on managing immune checkpoint inhibitors in oncology during the covid-19 era 34
A web-based scoping review assessing the influence of smoking and smoking cessation on antidiabetic drug meabolism: implications for medication efficacy 33
Targeting TNFSF10 as a novel immunotherapeutic strategy in Alzheimer’s disease 30
Correction: Musumeci et al. Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer’s Disease. Biomedicines 2022, 10, 985 28
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells 18
Monocyte-derived macrophages act as reinforcements when microglia fall short in Alzheimer’s disease 12
Targeting CD38 immunometabolic checkpoint improves metabolic fitness and cognition in a mouse model of Alzheimer’s disease 3
Totale 1.101
Categoria #
all - tutte 4.146
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.146


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 0 0 3 0
2020/202121 3 0 1 2 2 4 0 0 2 2 3 2
2021/202281 0 4 0 4 8 7 8 4 9 1 14 22
2022/2023218 15 14 6 30 11 36 5 28 49 3 11 10
2023/2024155 8 40 2 6 4 14 2 14 12 11 18 24
2024/2025601 23 82 46 28 108 67 76 17 93 49 12 0
Totale 1.101